Peptide Research Overviews: Compound-by-Compound Evidence
Compound research hub
The Research hub reviews individual peptides one compound at a time — what has actually been studied, how strong the human evidence is, and where the important gaps remain. Each overview is neutral, evidence-status labelled and contains no dosing or personal-use guidance.
Key points
- Each overview separates preclinical signals from proven human outcomes.
- Evidence-status labels show whether a compound is mainly preclinical, has limited human data, or is authorised.
- Overviews link to the relevant product, its batch documentation and related comparisons.
Compounds covered so far
Each overview follows the same structure: what the compound is, what has been studied, how much human evidence exists, and the limitations that remain.
- BPC-157 — a synthetic pentadecapeptide studied mainly in animal models.
- TB-500 & thymosin beta-4 — terminology, related sequences and evidence gaps.
- MOTS-c — a mitochondrial-derived peptide studied in metabolic research.
- GHK-Cu — a copper-binding tripeptide studied in skin and tissue research.
- Multi-peptide research blends — how blends complicate evidence and testing.
References & related reading
Related pages:
Explore the research catalogue
Browse Light Peptides research materials — each supplied with batch-specific documentation.
Browse the research catalogueFor laboratory research only. Not for human consumption.
